References
- 1. Halliday GM, McCann H. The progression of pathology in Parkinson’s disease. Annals of the New York Academy of Sciences. 2010;1184(1):188-95. DOI: 10.1111/j.1749-6632.2009.05118.x10.1111/j.1749-6632.2009.05118.x
- 2. Dauer W, Przedborski S. Parkinson’s disease: mechanisms and models. Neuron. 2003;39(6):889-909. DOI: 10.1016/S0896-6273(03)00568-310.1016/S0896-6273(03)00568-3
- 3. Santiago RM, Barbieiro J, Lima MM, Dombrowski PA, Andreatini R, Vital MA. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson’s disease are predominantly associated with serotonin and dopamine. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2010;34(6):1104-14. DOI: 10.1016/j.pnpbp.2010.06.00410.1016/j.pnpbp.2010.06.004
- 4. Mounsey RB, Teismann P. Mitochondrial dysfunction in Parkinson’s disease: pathogenesis and neuroprotection. Parkinson’s Disease. 2010;2011.10.4061/2011/617472
- 5. Sato K, Hatano T, Yamashiro K, Kagohashi M, Nishioka K, Izawa N, et al. Prognosis of Parkinson’s disease: time to stage III, IV, V, and to motor fluctuations. Movement disorders. 2006;21(9):1384-95. DOI: 10.1002/mds.2099310.1002/mds.20993
- 6. de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. The Lancet Neurology. 2006;5(6):525-35. DOI: 10.1016/S1474-4422(06)70471-910.1016/S1474-4422(06)70471-9
- 7. Lolaty HA, Tirgari A, Fard JH. Emotional intelligence and related factors in medical sciences students of an Iranian university. Iranian journal of nursing and midwifery research. 2014;19(2):203.
- 8. Fereshtehnejad S-M, Shafieesabet M, Rahmani A, Delbari A, Lökk J. Medium-to-high prevalence of screening- detected parkinsonism in the urban area of Tehran, Iran: data from a community-based door-to-door study. Neuropsychiatric disease and treatment. 2015;11:321. DOI: 10.2147/NDT.S7739110.2147/NDT.S77391
- 9. Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson’s disease. The Lancet Neurology. 2006;5(1):75-86. DOI: 10.1016/S1474-4422(05)70285-410.1016/S1474-4422(05)70285-4
- 10. Ciumas C, Montavont A, Ryvlin P. Magnetic resonance imaging in clinical trials. Current opinion in neurology. 2008;21(4):431-6. DOI: 10.1097/WCO.0b013e-3283056a3c
- 11. Halperin I, Morelli M, Korczyn AD, Youdim MB, Mandel SA. Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer’s and Parkinson’s diseases. Neurotherapeutics. 2009;6(1):128-40. DOI: 10.1016/j.nurt.2008.10.03310.1016/j.nurt.2008.10.033508426119110204
- 12. Casteleyn C, Prims S, Van Cruchten S, Van Ginneken C. Stereology: from astronomy to veterinary oncology. Veterinary journal (London, England: 1997). 2014;202(1):3-4. DOI: 10.1016/j.tvjl.2014.06.00110.1016/j.tvjl.2014.06.00124973003
- 13. Qualter P, Gardner KJ, Pope DJ, Hutchinson JM, Whiteley HE. Ability emotional intelligence, trait emotional intelligence, and academic success in British secondary schools: A 5year longitudinal study. Learning and Individual Differences. 2012;22(1):83-91. DOI: 10.1016/j.lindif.2011.11.00710.1016/j.lindif.2011.11.007
- 14. Brannick MT, Wahi MM, Goldin SB. Psychometrics of mayer-salovey-caruso emotional intelligence test (MSCEIT) scores 1. Psychological reports. 2011;109(1):327-37. DOI: 10.2466/03.04.PR0.109.4.327-33710.2466/03.04.PR0.109.4.327-33722049672
- 15. Duygulu S, Hicdurmaz D, Akyar I. Nursing students’ leadership and emotional intelligence in Turkey. Jour nal of Nursing Education. 2011;50(5):281-5. DOI: 10.3928/01484834-20110130-0710.3928/01484834-20110130-0721323258
- 16. Geng D-y, Li Y-X, Zee C-S. Magnetic resonance imaging- based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson’s disease. Neurosurgery. 2006;58(2):256-62. DOI: 10.1227/01.NEU.0000194845.19462.7B10.1227/01.NEU.0000194845.19462.7B16462479
- 17. Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss W-D. Differentiating multiple system atrophy from Parkinson’s disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. Journal of Neurology, Neurosurgery & Psychiatry. 2002;73(5):517-23. DOI: 10.1136/jnnp.73.5.51710.1136/jnnp.73.5.517173813112397143
- 18. Gocmen-Mas N, Pelin C, Canan S, Yazici AC, Zagyapan R, Senan S, et al. Stereological evaluation of volumetric asymmetry in healthy human cerebellum. Surgical and radiologic anatomy. 2009;31(3):177-81. DOI: 10.1007/s00276-008-0424-410.1007/s00276-008-0424-418941706
- 19. Heidari Z, Mahmoudzadeh-Sagheb H, Hashemi M, Rigi-Ladiz MA. Quantitative analysis of interdental Gingiva in patients with chronic periodontitis and transforming growth factor-β1 29C/T gene polymorphisms. Journal of periodontology. 2014;85(2):281-9. DOI: 10.1902/jop.2013.13008710.1902/jop.2013.13008723688102
- 20. Heidari Z, Mahmoudzadeh-Sagheb H, Kohan F. A quantitative and qualitative study of rat testis following administration of methadone and buprenorphine. International Journal of High Risk Behaviors and Addiction. 2012;1(1):14-7. DOI: 10.5812/ijhrba.411910.5812/ijhrba.4119
- 21. Lee CS, Schulzer M, de la Fuente-Fernández R, Mak E, Kuramoto L, Sossi V, et al. Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis. Archives of neurology. 2004;61(12):1920-5. DOI: 10.1001/archneur.61.12.192010.1001/archneur.61.12.192015596613
- 22. Lewis MM, Smith AB, Styner M, Gu H, Poole R, Zhu H, et al. Asymmetrical lateral ventricular enlargement in Parkinson’s disease. European journal of neurology. 2009;16(4):475-81. DOI: 10.1111/j.1468-1331.2008.02430.x10.1111/j.1468-1331.2008.02430.x290827319187264
- 23. Beyer MK, Janvin CC, Larsen JP, Aarsland D. A magneticresonance imaging study of patients with Parkinson’s disease with mild cognitive impairment and dementia using voxel-based morphometry. Journal of Neurology, Neurosurgery & Psychiatry. 2007;78(3):254-9. DOI: 10.1136/jnnp.2006.09384910.1136/jnnp.2006.093849211763317028119
- 24. Nagano-Saito A, Washimi Y, Arahata Y, Kachi T, Lerch J, Evans A, et al. Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology. 2005;64(2):224-9. DOI: 10.1212/01.WNL.0000149510.41793.5010.1212/01.WNL.0000149510.41793.5015668417
- 25. Fahn S, Group PS. Does levodopa slow or hasten the rate of progression of Parkinson’s disease? Journal of neurology. 2005;252(4):iv37-iv42. DOI: 10.1007/s00415-005-4008-510.1007/s00415-005-4008-516222436
- 26. Douaud G, Gaura V, Ribeiro M-J, Lethimonnier F, Maroy R, Verny C, et al. Distribution of grey matter atrophy in Huntington’s disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage. 2006;32(4):1562-75. DOI: 10.1016/j.neuroimage.2006.05.05710.1016/j.neuroimage.2006.05.05716875847
- 27. Mamah D, Wang L, Barch D, de Erausquin GA, Gado M, Csernansky JG. Structural analysis of the basal ganglia in schizophrenia. Schizophrenia research. 2007;89(1):59-71. DOI: 10.1016/j.schres.2006.08.03110.1016/j.schres.2006.08.031183981717071057
- 28. Summerfield C, Junqué C, Tolosa E, Salgado-Pineda P, Gómez-Ansón B, Martí MJ, et al. Structural brain changes in Parkinson disease with dementia: a voxel- based morphometry study. Archives of Neurology. 2005;62(2):281-5. DOI: 10.1001/archneur.62.2.28110.1001/archneur.62.2.28115710857
- 29. Cordato N, Duggins A, Halliday G, Morris J, Pantelis C. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain. 2005;128(6):1259-66. DOI: 10.1093/brain/awh50810.1093/brain/awh50815843423
- 30. Menke RA, Szewczyk‐Krolikowski K, Jbabdi S, Jenkinson M, Talbot K, Mackay CE, et al. Comprehensive morphometry of subcortical grey matter structures in early‐stage Parkinson’s disease. Human brain mapping. 2014;35(4):1681-90. DOI: 10.1002/hbm.2228210.1002/hbm.22282686897023861334
- 31. Sterling NW, Du G, Lewis MM, Dimaio C, Kong L, Eslinger PJ, et al. Striatal shape in Parkinson’s disease. Neurobiology of aging. 2013;34(11):2510-6. DOI: 10.1016/j.neurobiolaging.2013.05.01710.1016/j.neurobiolaging.2013.05.017374268623820588
- 32. Quattrone A, Nicoletti G, Messina D, Fera F, Condino F, Pugliese P, et al. MR imaging index for differentiation of progressive supranuclear palsy from parkinson disease and the parkinson variant of multiple system atrophy 1. Radiology. 2008;246(1):214-21. DOI: 10.1148/radiol.245306170310.1148/radiol.245306170317991785
- 33. Acharya HJ, Bouchard TP, Emery DJ, Camicioli RM. Axial signs and magnetic resonance imaging correlates in Parkinson’s disease. The Canadian Journal of Neurological Sciences. 2007;34(01):56-61. DOI: 10.1017/S031716710000579510.1017/S0317167100005795
- 34. Hu M, White S, Chaudhuri KR, Morris R, Bydder G, Brooks D. Correlating rates of cerebral atrophy in Parkinson’s disease with measures of cognitive decline. Journal of neural transmission. 2001;108(5):571-80. DOI: 10.1007/s00702017005710.1007/s00702017005711459077
- 35. Gama RL, Távora DF, Bomfim RC, Silva CE, Bruin VMd, Bruin PFd. Morphometry MRI in the differential diagnosis of parkinsonian syndromes. Arquivos de neuro- psiquiatria. 2010;68(3):333-8. DOI: 10.1590/S0004-282X201000030000110.1590/S0004-282X2010000300001
- 36. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC. Regional brain volumes distinguish PSP, MSA‐P, and PD: MRI‐based clinico‐radiological correlations. Movement disorders. 2006;21(7):989-96. DOI: 10.1002/mds.2087710.1002/mds.2087716602104
- 37. Ertekin T, Acer N, İçer S, Vurdem ÜE, Çınar Ş, Özçelik Ö. Volume estimation of the subcortical structures in Parkinson’s disease using magnetic resonance imaging: A methodological study. Neurology Asia. 2015;20(2):143-53.
- 38. Korbo L, Amrein I, Lipp HP, Wolfer D, Regeur L, Oster S, et al. No evidence for loss of hippocampal neurons in non‐Alzheimer dementia patients. Acta neurologica scandinavica. 2004;109(2):132-9. DOI: 10.1034/j.1600-0404.2003.00182.x10.1034/j.1600-0404.2003.00182.x14705976
- 39. Joelving F, Billeskov R, Christensen J, West M, Pakkenberg B. Hippocampal neuron and glial cell numbers in Parkinson’s disease-a stereological study. Hippocampus. 2006;16(10):826-33. DOI: 10.1002/hipo.2021210.1002/hipo.2021216941622
- 40. Jubault T, Brambati SM, Degroot C, Kullmann B, Strafella AP, Lafontaine A-L, et al. Regional brain stem atrophy in idiopathic Parkinson’s disease detected by anatomical MRI. PloS one. 2009;4(12):e8247. DOI: 10.1371/journal.pone.000824710.1371/journal.pone.0008247278429320011063
- 41. Toulouse A, Sullivan AM. Progress in Parkinson’s disease-where do we stand? Progress in neurobiology. 2008;85(4):376-92. DOI: 10.1016/j.pneurobio.2008.05.00310.1016/j.pneurobio.2008.05.00318582530